Investor List:

Top Pharmaceuticals Seed Investors in Canada (13)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Kunal Sethi, General Partner at Prithvi Ventures
Kunal Sethi
Prithvi Ventures·General Partner
Sweet spot: $1M
Range: $400K - $9.5M
Investors in Singapore, Investors in United Kingdom, Investors in Melbourne (Australia), Investors in Canada, Investors in United States, Investors in Europe
Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in AgTech (Seed), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Seed), Investors in New York City (Other Lists), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Canada (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Chemicals (Series A), Investors in Chemicals (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Seed), Investors in Chemicals (Series A), Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A)
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Hardware (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series A), Investors in Robotics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Hardware (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Hardware (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Canada (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Digital Health (Series B), Investors in Hardware (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Hardware (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Robotics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Jean-François Pariseau, Partner at Amplitude VC
Jean-François Pariseau
Amplitude VC·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Canada, Investors in Montreal
Investors in Medical Devices (Seed), Investors in Impact (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Impact (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in AI (Seed), Investors in Diverse Investors (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in AI (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in Impact (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Health IT (Series A), Investors in Impact (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Canada (Other Lists), Investors in Drug Delivery (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
Photo of Sandra Pérez Baos, Analyst at 2048 Ventures
Sandra Pérez Baos
2048 Ventures·Analyst
Sweet spot: $1.3M
Range: $500 - $2.0M
Investors in Canada, Investors in United Kingdom, Investors in United States
Photo of William Szczepaniak, Managing Director at UCeed Funds
William Szczepaniak
UCeed Funds·Managing Director
Sweet spot: $150K
Range: $50K - $300K
Investors in United States, Investors in Canada, Investors in Calgary
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Investors who were founders (Other Lists), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Canada (Other Lists), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Jeff Finkle, Managing Partner at Arcview Ventures
Jeff Finkle
Arcview Ventures·Managing Partner
Sweet spot: $150K
Range: $50K - $250K
Investors in United States, Investors in New York (NY), Investors in Israel, Investors in Canada
Investors in Retail (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in Media/Content (Seed), Investors in BioTech (Seed), Investors in Retail (Series A), Investors in Media/Content (Series A), Investors in AgTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Seed), Investors in New York City (Other Lists), Investors in Media/Content (Seed), Investors in Media/Content (Seed), Investors in Consumer Internet (Seed), Investors in Retail (Seed), Investors in SaaS (Seed), Investors in Retail (Seed), Investors in Media/Content (Seed), Investors in SaaS (Seed), Investors in Retail (Seed), Investors in Pharmaceuticals (Seed), Investors in SaaS (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Series A), Investors in BioTech (Series A), Investors in Consumer Internet (Series A), Investors in Retail (Series A), Investors in Media/Content (Series A), Investors in Media/Content (Series A), Investors in Retail (Series A), Investors in Media/Content (Series A), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in Retail (Series A), Investors in SaaS (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Canada (Other Lists), Investors in SaaS (Series A), Investors in Consumer Internet (Series A), Investors in SaaS (Seed)
Photo of Samantha Tabone, Partner at Empath Ventures
Samantha Tabone
Sweet spot: $100K
Range: $50K - $250K
Investors in Canada, Investors in Australia, Investors in Europe, Investors in United Kingdom, Investors in United States
Photo of Eric Blondeel, Venture Partner at Pioneer Fund
Eric Blondeel
Pioneer Fund·Venture Partner
Sweet spot: $250K
Range: $200K - $300K
Investors in Canada
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Canada (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)